Press "Enter" to skip to content

Nigeria targets 15% pharmaceutical market share in Africa by 2030 – Well being Minister  

The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, has introduced that the Presidential Initiative to Unlock the Healthcare Worth Chain (PVAC) is ready to spice up Nigeria’s pharmaceutical market share in Africa, with a goal of at the very least 15% by 2030.

He additionally disclosed that the initiative targets rising native manufacturing of pharmaceutical merchandise to fulfill at the very least 70% of our home demand by 2030.

Pate shared this on his X (previously Twitter) deal with on Friday.

Offering updates on the Presidential Initiative to Unlock the Healthcare Worth Chain, Prof. Pate emphasised the administration’s resolve to show the well being sector right into a hub for manufacturing and job creation.

“President Bola Ahmed Tinubu’s dedication to reworking the well being sector entails shifting from a consumption-driven mannequin to 1 that creates jobs, enhances financial worth, and strengthens home manufacturing capability whereas bettering the general productiveness of our economic system,” Pate wrote. 

Key objectives of the PVAC 

Launched in October 2023, the PVAC was established by President Tinubu, with Dr. Abdul Mukhtar appointed as its nationwide coordinator.

The initiative goals to extend native pharmaceutical manufacturing to at the very least 70% of Nigeria’s consumption by 2030.

It additionally targets increasing the life sciences manufacturing workforce from roughly 20,000 to 50,000 full-time workers establishing at the very least two commercially viable services for producing biologicals, together with vaccines and establishing at the very least 5 medical manufacturing vegetation within the nation

“This plan goals to double Nigeria’s pharmaceutical market share in Africa to at the very least 15% over time. I’m more than happy to report that for the reason that historic institution of this initiative, we have now achieved essential milestones,”Pate acknowledged. 

“We’re witnessing tangible outcomes from this effort. For too lengthy, Nigeria relied closely on imports for even essentially the most fundamental healthcare commodities,” Pate continued. “This authorities is dedicated to industrialization, job creation, and financial progress whereas guaranteeing that we stay aggressive in international commerce.” 

Memorandum of Understanding (MoU) with African Exim Bank 

Pate additionally shared particulars of the coverage’s early successes, together with the signing of a $1 billion memorandum of understanding (MoU) with the African Exim Bank, geared toward supporting home producers and attracting international investments.

“Over 70 new healthcare manufacturing corporations with robust initiatives backed by spectacular enterprise circumstances have already lined up with 22 large-scale initiatives at present in lively discussions with worldwide financiers.  

“Greater than 10 worth chain verticals have been established within the nation, together with manufacturing of speedy diagnostic cascades, which is exemplified by our signing of MOU South Africa-based natural diagnostics. 

Key initiatives and native manufacturing initiatives 

Moreover, Pate emphasised the significance of native manufacturing in lowering Nigeria’s reliance on imports for important medicines and healthcare provides, akin to vaccines, medical oxygen, and diagnostic kits.

Dr. Pate highlighted a number of key initiatives together with:

  • A cryogenic air separation plant for medical oxygen.
  • A speedy diagnostic equipment manufacturing facility in partnership with international companies.
  • A facility in Lagos produces lively pharmaceutical components like clavulanic acid, which has already created over 700 jobs.
  • Agreements with Siemens Healthineers to ascertain an ultrasound meeting plant in Nigeria.

He emphasised the function of regulators like NAFDAC and the Pharmacy Council of Nigeria in creating a sturdy surroundings that fosters native business progress.

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *